CORRINE GIGGEE: Open Payments
NPI 1467486480 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,725 in 94 payments from 13 companies in 2025. Trend: 2023 $2,063 · 2024 $2,792 · 2025 $5,725
Consulting: $3,190Food & beverage: $1,535Travel & lodging: $932Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 12 | $4,322 |
| ABBVIE INC. | 28 | $440 |
| Amgen Inc. | 21 | $307 |
| Janssen Biotech, Inc. | 7 | $214 |
| ANI Pharmaceuticals, Inc. | 13 | $186 |
| UCB, Inc. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Corcept Therapeutics | 2 | $39 |
| Radius Health, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: TREMFYA, RINVOQ, PURIFIED CORTROPHIN GEL, OTEZLA, SKYRIZI, Bimzelx, COSENTYX, TAVNEOS.
Industry payments across NE — which companies pay providers there.
